Among 3 analysts covering Exlservice Holdings (NASDAQ:EXLS), 2 have Buy rating, 0 Sell and 1 Hold. Therefore 67% are positive. Exlservice Holdings had 7 analyst reports since February 28, 2019 according to SRatingsIntel. The firm earned “Buy” rating on Thursday, February 28 by Cantor Fitzgerald. Citigroup maintained the stock with “Neutral” rating in Friday, March 1 report. The stock of ExlService Holdings, Inc. (NASDAQ:EXLS) has “Buy” rating given on Friday, March 1 by Barrington. See ExlService Holdings, Inc. (NASDAQ:EXLS) latest ratings:
17/07/2019 Broker: Inc. – Common Stock Rating: Citigroup 60.0000
22/05/2019 Broker: BidaskScore Rating: Buy Upgrade
01/03/2019 Broker: Barrington Rating: Buy New Target: $70 Maintain
01/03/2019 Broker: BidaskScore Rating: Buy Downgrade
01/03/2019 Broker: Citigroup Old Rating: Neutral New Rating: Neutral Old Target: $56 New Target: $62 Maintain
01/03/2019 Broker: Robert W. Baird Old Rating: Outperform New Rating: Neutral Downgrade
28/02/2019 Broker: Cantor Fitzgerald Rating: Buy New Target: $71 Maintain
Analysts expect Sutro Biopharma, Inc. (NASDAQ:STRO) to report $-0.62 EPS on August, 21.After having $-0.62 EPS previously, Sutro Biopharma, Inc.’s analysts see 0.00% EPS growth. The stock decreased 3.88% or $0.39 during the last trading session, reaching $9.67. About 6,738 shares traded. Sutro Biopharma, Inc. (NASDAQ:STRO) has 0.00% since August 13, 2018 and is . It has by 0.00% the S&P500.
More notable recent Sutro Biopharma, Inc. (NASDAQ:STRO) news were published by: Finance.Yahoo.com which released: “Is Sutro Biopharma (NASDAQ:STRO) Using Debt In A Risky Way? – Yahoo Finance” on July 31, 2019, also Seekingalpha.com with their article: “Wainwright sees 310% upside in Outlook Therapeutics in premarket analyst action – Seeking Alpha” published on July 18, 2019, Seekingalpha.com published: “Sutro Bio prices upsized IPO at $15 – Seeking Alpha” on September 26, 2018. More interesting news about Sutro Biopharma, Inc. (NASDAQ:STRO) were released by: Benzinga.com and their article: “The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trial Readouts – Benzinga” published on June 08, 2019 as well as Prnewswire.com‘s news article titled: “Sutro Biopharma Announces Encouraging Interim Phase 1 Safety Data on a Potential First-in-Class Antibody-Drug Conjugate STRO-001 for the Treatment of B-cell Malignancies at the European Hematology Association Congress – PRNewswire” with publication date: June 15, 2019.
Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. The company has market cap of $221.69 million. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis platform, XpressCF. It currently has negative earnings. The company's product candidates include STRO-001, an antibody-drug conjugate directed against the cancer target CD74 for multiple myeloma and non-Hodgkin lymphoma; and STRO-002, an ADC directed against folate receptor-alpha for patients with ovarian and endometrial cancers.
ExlService Holdings, Inc. provides operations management and analytics services in the United States, the United Kingdom, and internationally. The company has market cap of $2.31 billion. It operates in two divisions, Operations Management, and Analytics. It has a 50.96 P/E ratio. The Operations Management segment offers business process management services to the insurance industry in the areas of claims processing, subrogation, premium and benefit administration, agency management, account reconciliation, policy research, underwriting support, new business processing, policy servicing, premium audit, surveys, billing and collection, commercial and residential survey, and customer services.
Investors sentiment increased to 1.42 in Q1 2019. Its up 0.14, from 1.28 in 2018Q4. It increased, as 9 investors sold ExlService Holdings, Inc. shares while 51 reduced holdings. 25 funds opened positions while 60 raised stakes. 30.69 million shares or 2.84% less from 31.59 million shares in 2018Q4 were reported. Comml Bank Of Ny Mellon reported 0.01% of its portfolio in ExlService Holdings, Inc. (NASDAQ:EXLS). Citigroup invested 0% in ExlService Holdings, Inc. (NASDAQ:EXLS). Hood River holds 0.82% or 272,105 shares in its portfolio. Moreover, First Mercantile Tru has 0.03% invested in ExlService Holdings, Inc. (NASDAQ:EXLS). Ubs Asset Americas Inc holds 24,002 shares. Macquarie Gru owns 1.15 million shares for 0.12% of their portfolio. Btim holds 257,195 shares. Thomas White Int Limited reported 636 shares stake. State Teachers Retirement Systems invested in 19,700 shares or 0% of the stock. Vanguard Grp invested in 3.49M shares or 0.01% of the stock. Renaissance Tech Limited Liability Company has invested 0.03% in ExlService Holdings, Inc. (NASDAQ:EXLS). Amalgamated Bank & Trust, New York-based fund reported 5,369 shares. Eagle Asset Management Incorporated stated it has 198,909 shares. M&T Bankshares Corp, a New York-based fund reported 5,634 shares. Ameritas Inv Prtnrs Inc invested in 2,811 shares.
The stock decreased 0.82% or $0.56 during the last trading session, reaching $67.62. About 50,543 shares traded. ExlService Holdings, Inc. (NASDAQ:EXLS) has risen 15.89% since August 13, 2018 and is uptrending. It has outperformed by 15.89% the S&P500. Some Historical EXLS News: 01/05/2018 – ExlService 1Q EPS 66c; 01/05/2018 – ExlService: Aggregate Merger Consideration $240M; 17/04/2018 – ExlService Closes Above 200-Day Moving Average: Technicals; 23/04/2018 – DJ ExlService Holdings Inc, Inst Holders, 1Q 2018 (EXLS); 01/05/2018 – ExlService Agrees to Acquire SCIOInspire Holdings; 01/05/2018 – EXLSERVICE SEES FY ADJ EPS $2.70 TO $2.80, EST. $2.76; 15/03/2018 Report: Exploring Fundamental Drivers Behind Mountain Province Diamonds, Limoneira, Arsanis, ExlService, Argo Group Internation; 01/05/2018 – EXL deepens investment in Healthcare and Analytics by signing a definitive agreement to acquire payment integrity and populatio; 01/05/2018 – ExlService Sees FY Adj EPS $2.70-Adj EPS $2.80; 01/05/2018 – EXLSERVICE 1Q REV. $207.0M, EST. $203.9M
More notable recent ExlService Holdings, Inc. (NASDAQ:EXLS) news were published by: Finance.Yahoo.com which released: “Is ExlService Holdings, Inc.’s (NASDAQ:EXLS) CEO Being Overpaid? – Yahoo Finance” on August 06, 2019, also Finance.Yahoo.com with their article: “How Does Investing In ExlService Holdings, Inc. (NASDAQ:EXLS) Impact The Volatility Of Your Portfolio? – Yahoo Finance” published on July 19, 2019, Globenewswire.com published: “Exl Reports 2019 Second Quarter Results Nasdaq:EXLS – GlobeNewswire” on July 30, 2019. More interesting news about ExlService Holdings, Inc. (NASDAQ:EXLS) were released by: Nasdaq.com and their article: “ExlService Holdings (EXLS) Beats Q2 Earnings and Revenue Estimates – Nasdaq” published on July 30, 2019 as well as Globenewswire.com‘s news article titled: “EXL Named Among Fastest Growing Service Providers by Everest Group – GlobeNewswire” with publication date: July 15, 2019.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.